Why the study?
Does chronic PDE3 inhibition differentially affect cAMP levels and PDE activity in pediatric versus adult patients with idiopathic dilated cardiomyopathy?
Does chronic PDE3 inhibition differentially affect cAMP levels and PDE activity in pediatric versus adult patients with idiopathic dilated cardiomyopathy?
Chronic PDE3 inhibition increases cAMP and pPLB in pediatric but not adult IDC patients, providing a mechanistic explanation for the sustained hemodynamic benefits and relative safety of PDE3i in children compared to adults.
No takes yet. Share an insight, caveat, or question.
May inform age-specific PDE3i responses in pediatric IDC; leaves open validation of cAMP/PDE mechanisms in prospective studies.
Nakano et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: